Price Move History
- Daily moves over 5%
- 97 252 sessions, October 9, 2025 to October 9, 2026
- Largest daily move
- +66.7% close of October 31, 2025
- 1-year change
- +100% closing prices, October 9, 2025 to October 9, 2026
- 1-month change
- +33.3% closing prices, September 9, 2026 to October 9, 2026
Company Description
BIOELECTRONICS (OTC: BIEL) is classified in the medical devices industry within the Healthcare sector and carries a market capitalization of $4.9M.
BIEL has gained 100.0% over the past year. The last closing price was $0.0004.
This page collects what Stock Titan holds for BIEL, including price data, latest news, and short interest trends.
Stock Performance
BIOELECTRONICS (BIEL) closed at $0.0004 on October 9, 2026. Over the past 12 months, the price has gained 100.0%.
BIEL Metrics & Rankings
Price returns through October 9, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
BIOELECTRONICS has 10 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. Key topics include management, clinical trial. View all BIEL news →
SEC Filings
Short Interest History
Short interest in BIOELECTRONICS (BIEL) currently stands at 1.2 million shares, a new position with no short interest reported in the previous period, representing 0.0% of the float. Since October 2025, short interest has increased by 208.7%.
Days to Cover History
Days to cover for BIOELECTRONICS (BIEL) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.
BIEL Company Profile & Sector Positioning
BIOELECTRONICS (BIEL) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing BIEL often look at related companies in the same sector, including REMSLEEP HOLDINGS INC (RMSL), STIMCELL ENERGETICS INC (STME), ODYSSEY HEALTH INC (ODYY), KELYNIAM GLOBAL INC (KLYG), and ADM TRONICS UNLTD INC (ADMT). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BIEL's relative position within its industry.